» Articles » PMID: 36295562

Body Weight May Have a Role on Neuropathy and Mobility After Moderate to Severe COVID-19: An Exploratory Study

Overview
Publisher MDPI
Specialty General Medicine
Date 2022 Oct 27
PMID 36295562
Authors
Affiliations
Soon will be listed here.
Abstract

Background and Objectives: Among the extra-pulmonary manifestations of COVID-19, neuromuscular signs and symptoms are frequent. We aimed to assess the correlation between neuromuscular abnormalities (electrophysiological) and mobility measures (Berg Balance Scale and Timed-Up-and-Go test) twice, at least 6 weeks after hospital discharge and 6 months later, taking into account cognitive performance, nutrition, muscle strength, and submaximal exercise capacity. Materials and Methods: 43 patients (51.4 ± 9.3 years old) accepted to participate in the study; they had a dyspnea score ≤ 3 (Borg scale), and no history of neurology/neuromuscular/orthopedic disorders, but high frequency of overweight/obesity and weight loss during hospital stay. The two evaluations included physical examination, cognitive assessment, nutritional evaluation, muscle strength (hand-grip and quadriceps dynamometry), electromyography, Barthel Index, Six-Minute- Walk-Test (6MWT), Berg Balance Scale and Timed-Up-and-Go test. Bivariate and repeated measures covariance analyses were performed (significance level of 0.05). Results: Electrophysiological abnormalities were evident in 67% of the patients, which were associated with diminished performance on the 6MWT, the Berg Balance Scale and the Timed-Up-and-Go test. At each evaluation and between evaluations, scores on the Berg Balance Scale were related to the body mass index (BMI) at hospital admission and the 6MWT (MANCoVA R ≥ 0.62, p = 0.0001), while the time to perform the Timed-Up-and-Go test was related to the electrophysiological abnormalities, weight loss during hospital stay, sex, handgrip strength, and the 6MWT (MANCoVA, R ≥ 0.62, p < 0.0001). We concluded that, after hospital discharge, patients with moderate to severe COVID-19 may have neuromuscular abnormalities that can be related to BMI/weight loss, and contribute to mobility decrease. In patients with moderate to severe COVID-19 and high BMI/ large weight loss, neuromuscular and intended mobility assessments could be required to provide early rehabilitation. Apart from the 6MWT, handgrip dynamometry and the Timed-Up-and-Go test were useful tools to quickly assess fitness and mobility.

Citing Articles

Long COVID, the Brain, Nerves, and Cognitive Function.

Reiss A, Greene C, Dayaramani C, Rauchman S, Stecker M, Leon J Neurol Int. 2023; 15(3):821-841.

PMID: 37489358 PMC: 10366776. DOI: 10.3390/neurolint15030052.

References
1.
Lowry K, Vallejo A, Studenski S . Successful aging as a continuum of functional independence: lessons from physical disability models of aging. Aging Dis. 2012; 3(1):5-15. PMC: 3320804. View

2.
Cruz-Martinez A, Arpa J, Palau F . Peroneal neuropathy after weight loss. J Peripher Nerv Syst. 2000; 5(2):101-5. DOI: 10.1046/j.1529-8027.2000.00007.x. View

3.
Recalde M, Pistillo A, Fernandez-Bertolin S, Roel E, Aragon M, Freisling H . Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans. J Clin Endocrinol Metab. 2021; 106(12):e5030-e5042. PMC: 8344917. DOI: 10.1210/clinem/dgab546. View

4.
Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal A . Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?. J Cardiovasc Dev Dis. 2021; 8(11). PMC: 8621226. DOI: 10.3390/jcdd8110156. View

5.
Di Filippo L, De Lorenzo R, DAmico M, Sofia V, Roveri L, Mele R . COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. Clin Nutr. 2020; 40(4):2420-2426. PMC: 7598735. DOI: 10.1016/j.clnu.2020.10.043. View